Skip to main content

Table 1 Comparison between patients developed hematoma expansion (group I) and those did not (group II) regarding clinical and radiological data

From: Early hematoma expansion in primary intracerebral hemorrhage: incidence and predictors

  Group I
(n = 28)
Group II
(n = 44)
p value
Age 59.35 ± 10.51 54.58 ± 8.19 0.044*
Sex Male 13/28 (46.4%) 20/44 (45.5%) 0.953
Female 15/28 (53.6%) 24/44 (54.5%)
Diabetes 8/28 (28.6%) 14/44 (31.8%) 0.770
Smoking 13/28 (46.4%) 6/44 (13.6%) 0.0021*
Smoking index 20.71 ± 23.36 2.5 ± 6.77 < 0.0001*
Initial mean ABP 140.7 ± 22.45 104.3 ± 12.97 < 0.0001*
Initial m-NIHSS 17.29 ± 1.97 17.2 ± 2.74 < 0.0001*
Follow-up m-NIHSS difference 9.32 ± 3.86 3 ± 1.88 < 0.0001*
SMASH-U HTN 16/28 (57.1%) 24/44 (54.4%) 0.385
MI 4/28 (14.3%) 10/44 (22.7%)
SD 7/28 (25%) 7/44 (15.9%)
SVL 1/28 (3.6%) 3/44 (6.8%)
Hematoma Sites Lobar 12/28 (42.9%) 9/44 (20.5%) 0.077
Deep 13/28 (46.4%) 28/44 (63.6%)
Infratentorial 3/28 (10.7%) 7/44 (15.9%)
Intraventricular extension 9/28 (32.1%) 6/44 (13.6%) 0.059
Initial hematoma volume 31.19 ± 7.28 21.52 ± 5.28 < 0.0001*
Hematoma expansion volume 12.47 ± 5.36 1.78 ± 0.66 < 0.0001*
Hematoma irregular border 17/28 (60.7%) 11/44 (25%) 0.0024*
Blend sign 9/28 (32.1%) 4/44 (9.1%) 0.013*
Spot sign score 0.84 ± 0.76 0.11 ± 0.32 < 0.0001*
Mortality 15/28 (53.6%) 6/44 (13.6%) 0.0003*
Modified Rankin Scale 4.72 ± 1.24 3.1 ± 1.008 < 0.0001*
  1. ABP arterial blood pressure, HTN hypertension, MI medication induced, m-NIHSS modified National Institute of Health stroke scale, SD systemic disease, SVL structural vascular lesion
  2. *Significant